The Journal of Clinical Endocrinology & Metabolism · 1987 · 35 citations · 18 references
MedicineEndocrinologyOncologyEndocrine OncologyReproductive EndocrinologyReproductive MedicineGonadal EndocrinologyGonadal HormonesGonadal Steroid HormonesHormonal TherapyHormone SecretionHormone-secreting TumorsGnrh AgonistsGnrh AnaloguesGnrh Antagonist TherapyGnrh AntagonistsGonadal Hormone SecretionGonadotropin-releasing Hormone Agonist TherapyGonadotropin-releasing Hormone PharmacologyShort-term Observation
A GnRH superagonist, buserelin, was administered for 16 days to a postmenopausal woman with a testosterone-secreting ovarian tumor. Serum gonadotropin levels decreased by more than 70%, and serum testosterone fell by more than 50%. This short term study demonstrates that in these uncommon tumors androgen secretion is gonadotropin sensitive, and suggests that GnRH analogs may have therapeutic value in such patients.
18